Higher CRP concentrations at or after diagnosis (pre-treatment) have been reported to be associated with poor survival in CRC patients in a systematic review including 12 retrospective prognostic studies including 1705 patients in total [14], but in these studies, circulating CRP may reflect the presence of the tumor, which leads to both localized and systemic inflammatory response [6, 15]. This evidence concerns the gene CRP and neoplasm.